Wednesday, October 14, 2026
Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1
FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial
IceCure and Scovas agree for ProSense distribution in Netherlands
McKesson to buy Precision Medicine Group for $2.25bn

Insure Health

Random News
Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1
FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial
IceCure and Scovas agree for ProSense distribution in Netherlands
McKesson to buy Precision Medicine Group for $2.25bn

Insure Health

Random News
Headlines

Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1

FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial

IceCure and Scovas agree for ProSense distribution in Netherlands

McKesson to buy Precision Medicine Group for $2.25bn

Patient enrolment concludes in Senhwa’s Phase Ib trial of pidnarulex

Axoft launches Fleuron WISE polymer for advanced biological imaging

ViiV Healthcare’s Tivicay PD gains FDA approval for paediatric HIV therapy

HaemaLogiX doses first patient with KMCAR T-cell in KOALA trial

PENTAX broadens MAGENTIQ EYE partnership for global AI colonoscopy

FDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911

Monogram Health to pay $2.4M to settle Medicare Advantage upcoding allegations

Health Admin Hub01 mins

Monogram, a home health company, overcharged Medicare through contracts with Cigna and Humana by inflating diagnostic codes, according to the Justice Department.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News